The prevalence of multi-drug resistant organism (MDRO) colonization in nursing home residents has been well documented, but little is known about the impact of MDRO bloodstream infections (BSIs). The aim of this study was to assess the prevalence, cost, and outcomes of MDRO-BSI vs. non-MDRO-BSI among nursing home residents.
Design:
Retrospective cohort study
Setting:
960 bed tertiary academic medical center
Patients:
Persons ≥18 years old admitted to an acute care tertiary hospital from Skilled Nursing Facilities with a diagnosis of sepsis between 2015 and 2018.
Interventions:
Retrospective analysis of prevalence and outcomes.
Measurements and Main Results:
Among patients admitted to the study hospital with a diagnosis of sepsis during the study period, 7% were from nursing homes. The prevalence of MDRO-BSI was 47%. We identified 54 (50%) gram positive BSIs, 48 (45%) gram negative BSI and 5 (5%) fungal BSI. Thirty-one (57%) of the gram-positive infections and 14 (30%) of the gram-negative infections were with MDROs. The prevalence of BSI organisms were Staphylococcus aureus in 24%, Escherichia coli in 14%, Proteus mirabilis in 13%, Staphylococcus epidermidis in 8%, Enterococcus faecalis in 7%, and Klebsiella pneumoniae in 6%. We found that intensive care unit length of stay (7 days vs 5 days, P = .009), direct cost ($13,639 vs $9,922, P = .027), and total cost ($23,752 vs $17,900 P = .032) were significantly higher in patients with MDRO-BSI vs. non-MDRO-BSI. Patients with MDRO-BSI were twice as likely to receive inappropriate empiric antiinfective therapy (31% vs 16%, P = .006) and were more likely to die (49.1% vs 29.6%, P = .049).
Conclusion:
Nursing home residents have a high prevalence of MDRO-BSI, which is associated with higher risk of receiving inappropriate initial anti-infective therapy, higher cost, higher ICU LOS, and higher mortality. Our research adds new information about the prevalence of fungemia in this population.
OuslanderJGLambGPerloeM, et al.Potentially avoidable hospitalizations of nursing home residents: frequency, causes, and costs. J Am Geriatr Soc. 2010;58(4):627–635. doi:10.1111/j.1532-5415.2010.02768.x
2.
GindeAAMossMShapiroNISchwartzRS. Impact of older age and nursing home residence on clinical outcomes of US emergency department visits for severe sepsis. J Crit Care. 2013;28(5):606–611. doi:10.1016/j.jcrc.2013.03.018
3.
ReyesBJChangJVaynbergLDiazSOuslanderJG. Early identification and management of sepsis in nursing facilities: challenges and opportunities. J Am Med Dir Assoc. 2018;19(6):465–471. doi:10.1016/j.jamda.2018.04.004
4.
FayKSapianoMRPGokhaleR, et al.Assessment of health care exposures and outcomes in adult patients with sepsis and septic shock. JAMA Netw Open. 2020;3(7):e206004. doi:10.1001/jamanetworkopen.2020.6004
5.
WangHEShahMNAllmanRMKilgoreM. Emergency department visits by nursing home residents in the United States. J Am Geriatr Soc. 2011;59(10):1864–1872. doi:10.1111/j.1532-5415.2011.03587.x
6.
AliyuSCohenBLiuJLarsonE. Prevalence and risk factors for bloodstream infection present on hospital admission. J Infect Prev. 2018;19(1):37–42. doi:10.1177/1757177417720998
7.
AliyuSSmaldoneALarsonE. Prevalence of multidrug-resistant gram-negative bacteria among nursing home residents: a systematic review and meta-analysis. Am J Infect Control. 2017;45(5):512–518. doi:10.1016/j.ajic.2017.01.022
8.
DumyatiGStoneNDNaceDACrnichCJJumpRLP. Challenges and strategies for prevention of multidrug-resistant organism transmission in nursing homes. Curr Infect Dis Rep. 2017;19(4):18. doi:10.1007/s11908-017-0576-7
9.
ModyLRoghmannMC. Infrequent use of isolation precautions in nursing homes: implications for an evolving population. J Am Geriatr Soc. 2017;65(3):472–473. doi:10.1111/jgs.14781
10.
MitchellSLShafferMLLoebMB, et al.Infection management and multidrug-resistant organisms in nursing home residents with advanced dementia. JAMA Intern Med. 2014;174(10):1660–1667. doi:10.1001/jamainternmed.2014.3918
11.
CassoneMModyL. Colonization with multidrug-resistant organisms in nursing homes: scope, importance, and management. Curr Geriatr Reports. 2015;4(1):87–95. doi:10.1007/s13670-015-0120-2
KahveciogluDRamiahKMcMaughanD, et al.Multidrug-resistant organism infections in us nursing homes: a national study of prevalence, onset, and transmission across care settings, October 1, 2010-December 31, 2011. Infect Control Hosp Epidemiol.2014;35(S3):S48–S55. doi:10.1086/677835
BressmanERowlandJCNguyenVTRaucherBG. Severity of illness and the weekend mortality effect: a retrospective cohort study. BMC Health Serv Res. 2020;20(1):169. doi:10.1186/s12913-020-5029-6
16.
HarrisPATaylorRMinorBL, et al.The REDCap consortium: Building an international community of software platform partners. J Biomed Inform. 2019;95:103208. doi:10.1016/j.jbi.2019.103208
17.
MagiorakosAPSrinivasanACareyRB, et al.Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281. doi:10.1111/j.1469-0691.2011.03570.x
18.
HumphriesRMAmblerJMitchellSL, et al.CLSI methods development and standardization working group best practices for evaluation of antimicrobial susceptibility tests. J Clin Microbiol. 2018;56(4):e01934–02017. doi:10.1128/JCM.01934-17
19.
PokalaBFloresLArmijoPRKothariVOleynikovD.Robot-assisted cholecystectomy is a safe but costly approach: a national database review. Am J Surg. 2019;218(6):1213–1218. doi:10.1016/j.amjsurg.2019.08.014
20.
PatherKRavindranKGuerrierC, et al.Improved quality of care and efficiency do not always mean cost recovery after minimally invasive ivor lewis esophagectomy. J Gastrointest Surg. 2021:1–8. doi:10.1007/s11605-021-04931-4
21.
RedmannAJYuenSNVonAllmenD, et al.Does Surgical volume and complexity affect cost and mortality in otolaryngology–head and neck surgery?Otolaryngol Head Neck Surg. 2019;161(4):629–634. doi:10.1177/0194599819861524
22.
YoonJSYoonCWinklerEALiuCTorokILawtonMT. 158 a nationwide analysis of cost variation for cerebral aneurysm treatment. Neurosurgery. 2018;65(CN Suppl 1):100–101. doi:10.1093/neuros/nyy303.158
23.
AlnababtehMHHuangSSRyanAMcGowanKMYohannesS. A Multimodal Sepsis Quality-Improvement Initiative Including 24/7 Screening and a Dedicated Sepsis Response Team-Reduced Readmissions and Mortality. Crit Care Explor. 2020;2(12). doi:10.1097/cce.0000000000000251
24.
TorioCMMooreBJ. National Inpatient Hospital Costs: the Most Expensive Conditions by Payer, 2013: Statistical Brief #204. Agency for Healthcare Research and Quality; 2006.
25.
WalkeyAJWienerRS. Hospital case volume and outcomes among patients hospitalized with severe sepsis. Am J Respir Crit Care Med. 2014;189(5):548–555. doi:10.1164/rccm.201311-1967OC
26.
GreenbergJAHohmannSFJamesBD, et al.Hospital volume of immunosuppressed patients with sepsis and sepsis mortality. Ann Am Thorac Soc. 2018;15(8):962–969. doi:10.1513/AnnalsATS.201710-819OC
CapsoniNBellonePAlibertiS, et al.Prevalence, risk factors and outcomes of patients coming from the community with sepsis due to multidrug resistant bacteria. Multidiscip Respir Med. 2019;14(1):1–11. doi:10.1186/s40248-019-0185-4
29.
MarchaimDChopraTBoganC, et al.The burden of multidrug-resistant organisms on tertiary hospitals posed by patients with recent stays in long-term acute care facilities. Am J Infect Control. 2012;40(8):760–765. doi:10.1016/j.ajic.2011.09.011
30.
HarrisPPatersonDRogersB. Facing the challenge of multidrug-resistant gram-negative bacilli in Australia. Med J Aust. 2015;202(5):243–246. doi:10.5694/mja14.01257
31.
Garcia-VidalCViasusDRosetA, et al.Low incidence of multidrug-resistant organisms in patients with healthcare-associated pneumonia requiring hospitalization. Clin Microbiol Infect. 2011;17(11):1659–1665. doi:10.1111/j.1469-0691.2011.03484.x
32.
KalilACMeterskyMLKlompasM, et al.Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the infectious diseases society of America and the American thoracic society. Clin Infect Dis. 2016;63(5):e61–111. doi:10.1093/cid/ciw353
33.
IshiharaKAdachiMEguchiJWashizuMKosugiMOkudaK. Prevalence of staphylococcus species and candida albicans in the oral cavities of elderly who require daily care in a nursing home. Bull Tokyo Dent Coll. 2000;41(4):169–174. doi:10.2209/tdcpublication.41.169
34.
LiangLMooreBSoniA. National Inpatient Hospital Costs: The Most Expensive Conditions by Payer, 2017: Statistical Brief #261; 2006. Updated 2020. http://www.ncbi.nlm.nih.gov/pubmed/32833416
35.
JohnstonKJThorpeKEJacobJTMurphyDJ. The incremental cost of infections associated with multidrug-resistant organisms in the inpatient hospital setting-A national estimate. Health Serv Res. 2019;54(4):782–792. doi:10.1111/1475-6773.13135
36.
ThorpeKEJoskiPJohnstonKJ. Antibiotic-resistant infection treatment costs have doubled since 2002, now exceeding $2 billion annually. Health Aff. 2018;37(4):662–669. doi:10.1377/hlthaff.2017.1153
BurnhamJPLaneMAKollefMH. Impact of sepsis classification and multidrug-resistance status on outcome among patients treated with appropriate therapy. Crit Care Med. 2015;43(8):1580–1586. doi:10.1097/CCM.0000000000001013
39.
AliyuSFuruyaYLarsonE. Risk of subsequent health care–associated infection among patients with a bloodstream infection present on hospital admission. Am J Infect Control. 2019;47(2):196–200. doi:10.1016/j.ajic.2018.11.020
40.
ZilberbergMDShorrAFMicekSTVazquez-GuillametCKollefMH. Multi-drug resistance, inappropriate initial antibiotic therapy and mortality in Gram-negative severe sepsis and septic shock: a retrospective cohort study. Crit Care. 2014;18(6):596. doi:10.1186/s13054-014-0596-8
41.
GandraSTsengKKAroraA, et al.The mortality burden of multidrug-resistant pathogens in India: a retrospective, observational study. Clin Infect Dis.2019;69(4):563–570. doi:10.1093/cid/ciy955
